Network Pharmacology Integrated Molecular Docking Reveals the Mechanism of Anisodamine Hydrobromide Injection against Novel Coronavirus Pneumonia

BACKGROUND: The Coronavirus Disease 2019 (COVID-19) outbreak in Wuhan, China, was caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Anisodamine hydrobromide injection (AHI), the main ingredient of which is anisodamine, is a listed drug for improving microcirculation in China. A...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Evid Based Complement Alternat Med
Autors principals: Su, Jinsong, Liu, Zixuan, Liu, Chuan, Li, Xuanhao, Wang, Yi, Zhao, Jing, Wu, Qingjiang, Zheng, Shichao, Zhang, Yi
Format: Artigo
Idioma:Inglês
Publicat: Hindawi 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411467/
https://ncbi.nlm.nih.gov/pubmed/32802131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5818107
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars